Assessment of Anxiety, Depression, and Sleep Quality in Mothers of Children with Atopic Dermatitis: A Qualitative Questionnaire Study
- PMID: 37637475
- PMCID: PMC10460204
- DOI: 10.2147/JAA.S422534
Assessment of Anxiety, Depression, and Sleep Quality in Mothers of Children with Atopic Dermatitis: A Qualitative Questionnaire Study
Abstract
Purpose: To compare the anxiety, depression and sleep quality of mothers of healthy control children and mothers of children with atopic dermatitis (AD) of varying severity, both before and after treatment.
Methods: A total of 120 parent-child dyads participated in the study. These dyads were divided into four subgroups of 30 patients each: mild AD, moderate AD, severe AD, and control groups. The children's symptoms, their mothers' psychological status, and their mothers' sleep quality were evaluated using the Scoring of Atopic Dermatitis (SCORAD), the Hospital Anxiety and Depression Scale (HADS), and the Pittsburgh Sleep Quality Index (PSQI), respectively, before and after a one-month comprehensive treatment.
Results: SCORAD, representing differences in severity of children's AD, decreased significantly after one month's treatment (p < 0.001). Anxiety in mothers significantly decreased in all AD severity groups after treatment (p < 0.05). However, for depression, only the mothers in the mild and moderate AD groups showed a decrease after treatment (p < 0.05). The PSQI total score also decreased in the mild AD group after treatment (p < 0.05).
Conclusion: The most severe effect was seen in the psychology and sleep quality of mothers of children with severe AD. After one month of treatment, the psychological health and sleep quality of the mothers in the mild AD group significantly improved, while those of mothers in the moderate and severe AD groups showed partial improvement.
Keywords: atopic dermatitis; mothers; psychological health; questionnaire; sleep quality.
© 2023 Song et al.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Correlation between Severity of Atopic Dermatitis and Sleep Quality in Children and Adults.Ann Dermatol. 2016 Jun;28(3):321-6. doi: 10.5021/ad.2016.28.3.321. Epub 2016 May 25. Ann Dermatol. 2016. PMID: 27274630 Free PMC article.
-
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9. J Dermatolog Treat. 2020. PMID: 31179791 Clinical Trial.
-
Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.Br J Dermatol. 2019 Sep;181(3):554-565. doi: 10.1111/bjd.17683. Epub 2019 Mar 5. Br J Dermatol. 2019. PMID: 30838645 Free PMC article.
-
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.Dermatol Ther (Heidelb). 2022 Dec;12(12):2653-2668. doi: 10.1007/s13555-022-00819-6. Epub 2022 Oct 5. Dermatol Ther (Heidelb). 2022. PMID: 36197589 Free PMC article. Review.
-
Patient-reported outcome (PRO) instruments for disease severity and quality of life in patients with atopic dermatitis: a systematic review of English and Chinese literature.Ann Transl Med. 2022 Aug;10(16):906. doi: 10.21037/atm-22-3164. Ann Transl Med. 2022. PMID: 36111032 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources